Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Japan Drug Imports Exceeds ¥1 Trillion, Trade Deficit at ¥700 Billion

This article was originally published in PharmAsia News

Executive Summary

Japan's trade data for 2007, released by the Department of Treasury, shows that the country's import of drugs increased by 8.8 percent to ¥1.078 trillion. EU was the biggest exporter, sending ¥634.4 billion worth of drugs to Japan and followed by the U.S., ¥168.3 billion. Import from China jumped 33.1 percent to ¥46.9 billion. Japan exported ¥374.4 billion worth of drugs in 2007, a 0.6 percent increase. The biggest importer of Japanese drugs was the U.S., with a total of ¥127 billion, and followed by EU, ¥119 billion. Japan's export to China was ¥22.7 billion. (Click here for more - Japanese language

Table

View full table

Tags:
Latest Headlines

BridgeBio Spins Out Cancer Arm With $200m Fundraise

Emergex Goes To Battle Against ‘The Nasties’

Finance Watch: Venture Rounds Trend Toward The High End

The UK’s Cancer Vaccine Partnership With BioNTech Is Another First – But Can It Deliver?

See All
UsernamePublicRestriction

Register

SC069352

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By